Want to see MDXH full AI Analyst Report?
MDxHealth (MDXH) Ratios
MDxHealth Ratios
MDXH's free cash flow for Q2 2026 was $-5.89M. For the 2026 fiscal year, MDXH's free cash flow was decreased by $-39.00K and operating cash flow was $-5.85M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.08 | 1.57 | 1.95 | 1.59 | 4.05 |
| Quick Ratio | 0.94 | 1.48 | 1.81 | 1.47 | 3.94 |
| Cash Ratio | 0.59 | 1.10 | 1.15 | 0.85 | 3.56 |
| Solvency Ratio | -0.15 | -0.21 | -0.30 | -0.36 | -0.92 |
| Operating Cash Flow Ratio | -0.21 | -0.43 | -1.10 | -1.87 | -1.37 |
| Short-Term Operating Cash Flow Coverage | -5.49 | -57.19 | -33.43 | -55.39 | -5.08 |
| Net Current Asset Value | $ -106.64M | $ -75.59M | $ -83.76M | $ -80.67M | $ 38.43M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.64 | 0.38 | 0.32 | 0.33 | 0.21 |
| Debt-to-Equity Ratio | -7.86 | 4.05 | 5.72 | 4.27 | 0.33 |
| Debt-to-Capital Ratio | 1.15 | 0.80 | 0.85 | 0.81 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 1.17 | 0.77 | 0.83 | 0.79 | 0.14 |
| Financial Leverage Ratio | -12.23 | 10.60 | 17.92 | 12.79 | 1.60 |
| Debt Service Coverage Ratio | -0.86 | -2.82 | -4.75 | -10.83 | -3.81 |
| Interest Coverage Ratio | -1.27 | -3.24 | -4.73 | -13.82 | -14.32 |
| Debt to Market Cap | 0.48 | 0.44 | 0.35 | 0.34 | 0.10 |
| Interest Debt Per Share | 2.14 | 1.39 | 1.82 | 2.68 | 1.43 |
| Net Debt to EBITDA | -4.72 | -0.60 | -0.62 | -0.67 | 1.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 59.74% | 61.23% | 62.58% | 51.87% | 47.50% |
| EBIT Margin | -21.52% | -33.38% | -53.18% | -111.46% | -121.98% |
| EBITDA Margin | -12.98% | -24.45% | -43.41% | -98.21% | -108.33% |
| Operating Profit Margin | -14.28% | -27.45% | -38.93% | -102.28% | -120.69% |
| Pretax Profit Margin | -32.79% | -41.85% | -61.40% | -118.86% | -130.41% |
| Net Profit Margin | -31.07% | -42.28% | -61.40% | -118.86% | -130.41% |
| Continuous Operations Profit Margin | -31.07% | -42.28% | -61.40% | -118.86% | -130.41% |
| Net Income Per EBT | 94.75% | 101.01% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 229.70% | 152.44% | 157.72% | 116.21% | 108.05% |
| Return on Assets (ROA) | -22.66% | -24.20% | -33.38% | -36.97% | -38.63% |
| Return on Equity (ROE) | 277.15% | -256.51% | -597.95% | -472.83% | -61.84% |
| Return on Capital Employed (ROCE) | -15.65% | -21.56% | -24.93% | -37.58% | -45.77% |
| Return on Invested Capital (ROIC) | -14.55% | -21.25% | -24.46% | -36.92% | -41.99% |
| Return on Tangible Assets | -48.17% | -47.11% | -88.19% | -118.90% | -40.49% |
| Earnings Yield | -18.77% | -33.01% | -42.22% | -42.00% | -24.98% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.32 | 6.20 | 6.23 | 3.96 | 4.85 |
| Payables Turnover | 4.20 | 4.36 | 2.98 | 1.75 | 1.57 |
| Inventory Turnover | 6.44 | 9.02 | 9.45 | 7.66 | 6.11 |
| Fixed Asset Turnover | 7.35 | 6.94 | 7.06 | 4.69 | 4.43 |
| Asset Turnover | 0.73 | 0.57 | 0.54 | 0.31 | 0.30 |
| Working Capital Turnover Ratio | 7.68 | 4.20 | 4.76 | 1.21 | 0.74 |
| Cash Conversion Cycle | 19.67 | 15.70 | -25.22 | -68.50 | -98.12 |
| Days of Sales Outstanding | 49.83 | 58.90 | 58.61 | 92.17 | 75.20 |
| Days of Inventory Outstanding | 56.65 | 40.45 | 38.62 | 47.62 | 59.74 |
| Days of Payables Outstanding | 86.81 | 83.66 | 122.45 | 208.30 | 233.07 |
| Operating Cycle | 106.48 | 99.36 | 97.23 | 139.79 | 134.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.21 | -0.38 | -0.83 | -2.15 | -1.85 |
| Free Cash Flow Per Share | -0.23 | -0.43 | -1.02 | -2.41 | -1.92 |
| Dividend Paid and CapEx Coverage Ratio | -9.00 | -8.58 | -4.28 | -8.20 | -25.17 |
| Capital Expenditure Coverage Ratio | -9.00 | -8.58 | -4.28 | -8.20 | -25.17 |
| Operating Cash Flow Coverage Ratio | -0.11 | -0.31 | -0.52 | -0.86 | -1.45 |
| Operating Cash Flow to Sales Ratio | -0.10 | -0.21 | -0.31 | -0.92 | -1.01 |
| Free Cash Flow Yield | -6.48% | -17.94% | -25.97% | -36.50% | -20.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.33 | -3.04 | -2.37 | -2.38 | -4.00 |
| Price-to-Sales (P/S) Ratio | 1.66 | 1.28 | 1.45 | 2.83 | 5.22 |
| Price-to-Book (P/B) Ratio | -14.77 | 7.77 | 14.16 | 11.26 | 2.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.43 | -5.57 | -3.85 | -2.74 | -4.95 |
| Price-to-Operating Cash Flow Ratio | -17.15 | -6.22 | -4.75 | -3.07 | -5.15 |
| Price-to-Earnings Growth (PEG) Ratio | 0.38 | 0.06 | 0.06 | -0.14 | 0.13 |
| Enterprise Value Multiple | -17.47 | -5.84 | -3.97 | -3.55 | -3.04 |
| Enterprise Value | 244.68M | 128.60M | 120.97M | 129.16M | 73.14M |
| EV to EBITDA | -17.47 | -5.84 | -3.97 | -3.55 | -3.04 |
| EV to Sales | 2.27 | 1.43 | 1.72 | 3.49 | 3.29 |
| EV to Free Cash Flow | -21.14 | -6.22 | -4.56 | -3.37 | -3.12 |
| EV to Operating Cash Flow | -23.49 | -6.94 | -5.63 | -3.79 | -3.24 |
| Tangible Book Value Per Share | -1.81 | -1.27 | -2.82 | -4.59 | 3.56 |
| Shareholders’ Equity Per Share | -0.24 | 0.30 | 0.28 | 0.59 | 3.85 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.05 | -0.01 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.16 | 1.85 | 2.71 | 2.34 | 1.82 |
| Net Income Per Share | -0.67 | -0.78 | -1.66 | -2.78 | -2.38 |
| Tax Burden | 0.95 | 1.01 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.52 | 1.25 | 1.15 | 1.07 | 1.07 |
| Research & Development to Revenue | 0.10 | 0.12 | 0.09 | 0.20 | 0.25 |
| SG&A to Revenue | 0.62 | 0.68 | 0.33 | 0.64 | 1.22 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.01 | 0.02 | 0.05 |
| Income Quality | 0.72 | 0.75 | 0.79 | 0.90 | 0.84 |
Currency in USD